Picture of Cyclo Therapeutics logo

CYTH — Cyclo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Cyclo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

* Cyclo Therapeutics Inc  CYTH.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -33 cents.  The mean expectation of two analysts
for the quarter was for a loss of 15 cents per share. Wall
Street expected results to range from -17 cents to -14 cents per
share.
    * Revenue rose 5.1% to $123.00 thousand from a year ago;
analysts
expected $267.50 thousand. 
    * Cyclo Therapeutics Inc's reported EPS for the quarter was
a loss
of 21 cents​.
    * The company reported a quarterly loss of $5.98 million.
    * Cyclo Therapeutics Inc shares had fallen by 6.3% this
quarter and lost 25.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 8.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Cyclo
Therapeutics Inc is $3.00 
This summary was machine generated from LSEG data August 16 at
12:37 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.15          -0.21          Missed
 Mar. 31 2024      -0.20          -0.15          Beat
                                  -0.34          
                                  -0.29

Recent news on Cyclo Therapeutics

See all news